These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

604 related items for PubMed ID: 2836550

  • 41. Genomic analysis of Epstein-Barr virus in nasal and peripheral T-cell lymphoma: a comparison with nasopharyngeal carcinoma in an endemic area.
    Wu SJ, Lay JD, Chen CL, Chen JY, Liu MY, Su IJ.
    J Med Virol; 1996 Dec; 50(4):314-21. PubMed ID: 8950688
    [Abstract] [Full Text] [Related]

  • 42. CpG methylation of viral DNA in EBV-associated tumours.
    Allday MJ, Kundu D, Finerty S, Griffin BE.
    Int J Cancer; 1990 Jun 15; 45(6):1125-30. PubMed ID: 2161800
    [Abstract] [Full Text] [Related]

  • 43. [Latency of Epstein-Barr virus and its relationship to nasopharyngeal carcinomas].
    You S, Yao K, Cao Y.
    Zhonghua Zhong Liu Za Zhi; 1996 Jan 15; 18(1):23-6. PubMed ID: 8732106
    [Abstract] [Full Text] [Related]

  • 44. Host cell-dependent regulation of growth transformation-associated Epstein-Barr virus antigens in somatic cell hybrids.
    Contreras-Salazar B, Klein G, Masucci MG.
    J Virol; 1989 Jun 15; 63(6):2768-72. PubMed ID: 2542588
    [Abstract] [Full Text] [Related]

  • 45. Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease.
    Pallesen G, Hamilton-Dutoit SJ, Rowe M, Young LS.
    Lancet; 1991 Feb 09; 337(8737):320-2. PubMed ID: 1671232
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Monoclonal and polyclonal antibodies against Epstein-Barr virus nuclear antigen 5 (EBNA-5) detect multiple protein species in Burkitt's lymphoma and lymphoblastoid cell lines.
    Finke J, Rowe M, Kallin B, Ernberg I, Rosén A, Dillner J, Klein G.
    J Virol; 1987 Dec 09; 61(12):3870-8. PubMed ID: 2824821
    [Abstract] [Full Text] [Related]

  • 49. Establishment of an Epstein-Barr virus (EBV) genome-positive subline of Ramos (Ramos/NPC) following infection of Ramos with nasopharyngeal carcinoma (NPC)-derived EBV.
    Takimoto T, Sato H, Ogura H, Miyazaki T.
    Auris Nasus Larynx; 1987 Dec 09; 14(2):87-92. PubMed ID: 2835030
    [Abstract] [Full Text] [Related]

  • 50. Complementary serum test of antibodies to Epstein-Barr virus nuclear antigen-1 and early antigen: a possible alternative for primary screening of nasopharyngeal carcinoma.
    Chang KP, Hsu CL, Chang YL, Tsang NM, Chen CK, Lee TJ, Tsao KC, Huang CG, Chang YS, Yu JS, Hao SP.
    Oral Oncol; 2008 Aug 09; 44(8):784-92. PubMed ID: 18206420
    [Abstract] [Full Text] [Related]

  • 51. Latency pattern of Epstein-Barr virus and methylation status in Epstein-Barr virus-associated hemophagocytic syndrome.
    Yoshioka M, Kikuta H, Ishiguro N, Endo R, Kobayashi K.
    J Med Virol; 2003 Jul 09; 70(3):410-9. PubMed ID: 12767005
    [Abstract] [Full Text] [Related]

  • 52. Transcriptional analysis of Epstein-Barr virus gene expression in EBV-positive gastric carcinoma: unique viral latency in the tumour cells.
    Sugiura M, Imai S, Tokunaga M, Koizumi S, Uchizawa M, Okamoto K, Osato T.
    Br J Cancer; 1996 Aug 09; 74(4):625-31. PubMed ID: 8761381
    [Abstract] [Full Text] [Related]

  • 53. V-val subtype of Epstein-Barr virus nuclear antigen 1 preferentially exists in biopsies of nasopharyngeal carcinoma.
    Zhang XS, Wang HH, Hu LF, Li A, Zhang RH, Mai HQ, Xia JC, Chen LZ, Zeng YX.
    Cancer Lett; 2004 Jul 28; 211(1):11-8. PubMed ID: 15194212
    [Abstract] [Full Text] [Related]

  • 54. Epstein-Barr virus nuclear protein 2 mutations define essential domains for transformation and transactivation.
    Cohen JI, Wang F, Kieff E.
    J Virol; 1991 May 28; 65(5):2545-54. PubMed ID: 1850028
    [Abstract] [Full Text] [Related]

  • 55. In nasopharyngeal carcinoma cells, Epstein-Barr virus LMP1 interacts with galectin 9 in membrane raft elements resistant to simvastatin.
    Pioche-Durieu C, Keryer C, Souquère S, Bosq J, Faigle W, Loew D, Hirashima M, Nishi N, Middeldorp J, Busson P.
    J Virol; 2005 Nov 28; 79(21):13326-37. PubMed ID: 16227255
    [Abstract] [Full Text] [Related]

  • 56. Polymyositis/dermatomyositis and nasopharyngeal carcinoma: the Epstein-Barr virus connection?
    Chen DY, Chen YM, Lan JL, Chen HH, Hsieh CW, Wey SJ, Lu JJ.
    J Clin Virol; 2010 Dec 28; 49(4):290-5. PubMed ID: 20934910
    [Abstract] [Full Text] [Related]

  • 57. Titers of Epstein-Barr virus-related antibodies in nasopharyngeal carcinoma in Japan.
    Tamada A, Makimoto K, Yamabe H, Imai J, Hinuma Y, Oyagi A, Araki T.
    Cancer; 1984 Feb 01; 53(3):430-40. PubMed ID: 6318948
    [Abstract] [Full Text] [Related]

  • 58. Transcription of the Epstein-Barr virus gene EBNA-1 from different promoters in nasopharyngeal carcinoma and B-lymphoblastoid cells.
    Smith PR, Griffin BE.
    J Virol; 1992 Feb 01; 66(2):706-14. PubMed ID: 1370554
    [Abstract] [Full Text] [Related]

  • 59. In vitro EBV-infected subline of KMH2, derived from Hodgkin lymphoma, expresses only EBNA-1, while CD40 ligand and IL-4 induce LMP-1 but not EBNA-2.
    Kis LL, Nishikawa J, Takahara M, Nagy N, Matskova L, Takada K, Elmberger PG, Ohlsson A, Klein G, Klein E.
    Int J Cancer; 2005 Mar 01; 113(6):937-45. PubMed ID: 15514968
    [Abstract] [Full Text] [Related]

  • 60. Precipitation of the Epstein-Barr virus protein EBNA 2 by an EBNA 3c-specific monoclonal antibody.
    Maunders MJ, Petti L, Rowe M.
    J Gen Virol; 1994 Apr 01; 75 ( Pt 4)():769-78. PubMed ID: 7512118
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 31.